Partnerships

We are developing the Livegrid platform through targeted collaborations. We are interested in projects that cannot be carried out using standard organoid, spheroid, or organ-on-chip models.

Pharma and biotech

We are open to pilot studies and co-development projects involving drug metabolism, DILI, cholestasis, neurotoxicity, epilepsy, and chronic disease models.

Typical collaboration goals:

Benchmark a Livegrid model against an internal assay.
Develop a disease-specific model.
Test compounds in perfused tissue over longer durations.
Combine functional, imaging, biochemical, and omics readouts.

CROs and assay developers

Livegrid can support partners interested in developing validated services based on perfused liver or neural tissue models.

Our contributions include certified assay workflows, tissue-in-chip supply, platform access, and partner-run services.

Academic groups

We work with academic groups focused on advanced tissue models, disease biology, vascular biology, neural interfaces, or long-term functional assays.

Research collaborations should generate clear biological validation data or lead to new applications for the platform.

Technology partners

Relevant partners include microfluidics manufacturers, cell suppliers, tissue-machine interface developers, optical systems companies, automation providers, and AI-driven drug discovery companies.